Archives
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
Pifithrin-α (PFTα): Precision Modulation of p53 for Trans...
2025-09-29
Discover how Pifithrin-α (PFTα), a potent p53 inhibitor, enables advanced translational research in neuroprotection, DNA damage response, and stem cell modulation. This article uniquely explores PFTα's role in mitigating environmental neurotoxicity and guiding cell fate, providing novel insights for apoptosis and ferroptosis research.
-
Crizotinib Hydrochloride: Transforming Patient-Derived Tu...
2025-09-28
Discover how Crizotinib hydrochloride, a potent ALK kinase inhibitor, is redefining cancer biology research by empowering advanced patient-derived tumor assembloid models. Uncover its mechanistic depth, translational applications, and unique potential for unraveling oncogenic signaling and drug resistance.
-
Rucaparib (AG-014699): Advanced Mechanistic Insights for ...
2025-09-27
Explore how Rucaparib (AG-014699), a potent PARP1 inhibitor, uniquely integrates DNA damage response research with emerging apoptotic signaling pathways. This article delivers a deep analysis of Rucaparib’s mechanistic roles in PTEN-deficient and ETS fusion-expressing cancer models, revealing novel intersections with mitochondrial signaling and RNA Pol II degradation.
-
2025-09-26
Explore how Anti Reverse Cap Analog (ARCA), 3´-O-Me-m7G(5')ppp(5')G, serves as a next-generation mRNA cap analog for enhanced translation. This article uniquely integrates ARCA’s biochemical mechanism with emerging insights in metabolic regulation and translational control, offering a fresh perspective for mRNA therapeutics research.
-
L1023 Anti-Cancer Compound Library: Accelerating Biomarke...
2025-09-25
Explore how the L1023 Anti-Cancer Compound Library empowers biomarker-guided cancer research and next-generation target discovery. Gain unique insights into integrating high-throughput screening with molecular profiling to advance precision oncology.
-
ISRIB (trans-isomer): Unlocking New Frontiers in Targeted...
2025-09-24
Explore how ISRIB (trans-isomer), a powerful integrated stress response inhibitor, is revolutionizing ER stress research and fibrosis modeling. This in-depth article reveals novel mechanistic insights and advanced applications for cognitive and fibrotic disease models.
-
Vardenafil HCl Trihydrate in Native Membrane PDE5 Inhibit...
2025-09-23
Explore how Vardenafil HCl Trihydrate, a potent and selective PDE5 inhibitor, enables nuanced studies of cGMP signaling and proteoform-specific interactions within native cell environments. This article examines its utility in advanced smooth muscle relaxation and erectile dysfunction models.
-
br Disclosure br Acknowledgments br Introduction Anaplastic
2025-03-03
Disclosure Acknowledgments Introduction Anaplastic lymphoma kinase (ALK), a receptor tyrosine kinase, belongs to the insulin receptor kinase subfamily [1]. Oncogenic activation of ALK is associated with the In vitro transcription labeling and progression of multiple human cancer types [2,3
-
High-fidelity DNA polymerase Cells have developed strategies
2025-03-03
Cells have developed strategies aiming to enhance both the efficiency of proteins with chaperone activity as well as their overall antioxidant capacity to maintain proteostasis under oxidative stress conditions (Miyata et al., 2012). For instance, 2-Cys peroxiredoxin is an abundantly expressed, anti
-
Blocking the action of CREB
2025-03-03
Blocking the action of CREB with the C646 inhibitor together with increasing Akt activation with the SC79 agonist is particularly interesting as it significantly reduced wound closure time from 7 days (which is required for complete closure of control hTECs exposed to DMSO) to only 4 days (when hTEC
-
Though we have proved that VA could suppress hepatic
2025-03-03
Though, we have proved that VA could suppress hepatic gluconeogenesis, the mechanisms of VA on gluconeogenesis in vivo and in vitro remain unclear. AMP-activated protein kinase (AMPK), which is called an energy receptor enzyme, is widely expressed in liver and other tissues [23]. AMPK has become ano
-
B lymphocytes are found in
2025-03-03
B lymphocytes are found in blood, lymph nodes, spleen and tonsil and other mucosal tissues [110]. These cells originate in the bone marrow from a common progenitor shared with T, NK, and some DC subsets [111]. Progenitor BMS 195614 receptor progress through the early stages of maturation, rearrangi
-
Autophagy is finalized through the coordinated positioning a
2025-03-03
Autophagy is finalized through the coordinated positioning and fusion of autophagosomes with lysosomes, during which an array of common and specific membrane traffic-associated proteins is mobilized. Among these proteins, small GTPases, like Rab7, Rab34, or Arl8, and their 4 oht proteins, regulate
-
br Conflict of interest statement br Acknowledgments
2025-03-01
Conflict of interest statement Acknowledgments Introduction Cellular responses to genotoxic stress in eukaryotic cells are coordinated by members of the phosphoinositide kinase related protein kinase (PIKK) family. Two members of this family, Ataxia–Telangiectasia mutated (ATM) and ATM and
-
In this study we showed that
2025-03-01
In this study, we showed that TRIM48 promotes ASK1 activation through ubiquitination-dependent degradation of a negative regulator of ASK1 activation, protein arginine methyltransferase 1 (PRMT1). Knocking down TRIM48 suppressed oxidative-stress-induced cell death mediated by ASK1, and the additiona